Top 5 Pharmacy Times Oncology Articles in 2022
New drug approvals, toxicity management, and pharmacists’ roles in cancer care all dominated the top oncology articles of 2022.
1. Help Manage Toxicities With BRAF and MEK Inhibitors
Watch for alopecia, arthralgia, diarrhea, fatigue, nausea, pyrexia, rash, and vomiting, among others. Read more.
2. Janssen Submits BLA for Teclistamab in Patients With Relapsed or Refractory Multiple Myeloma
The submission is supported by data from MajesTEC-1, a multicenter clinical trial evaluating the safety and efficacy of teclistamab in adults with RRMM. Read more.
3. Niraparib as First-Line Maintenance Treatment of Ovarian, Fallopian Tube, Primary Peritoneal Cancer
The oral PARP inhibitor is associated with increased progression-free survival, regardless of BRCA mutational status. Read more.
4. Depression Screenings Improve Care for Patients With Cancer
Incorporating mental distress screenings during cancer care has been historically difficult, despite the fact that these patients tend to be vulnerable to mental health challenges. Read more.
5. Oncology Pharmacists Are Essential in Therapeutic Interchange
Biosimilar therapeutic interchange processes can mitigate high costs of cancer drugs. Read more.
